Splice variant HE4-V3 expression is associated with favorable prognosis in pulmonary adenocarcinoma

Tumor Biology

Volumn 33, Issue 1, 2012, Pages 103-109

  Tokuishi, Keita ^a   Yamashita, Shin Ichi ^a   Ohbo, Kazuyuki ^b   Kawahara, Katsunobu ^a  

^a OITA UNIVERSITY   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Adenocarcinoma; HE4; Lung; Splice variant; WFDC2

Indexed keywords

MESSENGER RNA;

ARTICLE; CANCER INVASION; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN EPIDIDYMIS 4 GENE; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RNA SPLICING; SURVIVAL RATE; SURVIVAL TIME; TUMOR GENE; TUMOR VOLUME;

EID: 83655182500     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-011-0252-8     Document Type: Article

References (19)

1. CF Mountain 1997 Revisions in the international system for staging lung cancer Chest 111 1710 1717 9187198 10.1378/chest.111.6.1710 1:STN:280: DyaK2szjtVOguw%3D%3D (Pubitemid 27260107)
2. Pass HI, Carbone DP, Johnson DH, Minna JD, Scagliotti GV, Turrisi III AT (2009) Principles and practice of lung cancer, 4th edn. Philadelphia, Lippincott Williams & Wilkins
3. L Bingle V Singleton CD Bingle 2002 The putative ovarian tumour marker gene HE4 (WFDC2), is expressed in normal tissues and undergoes complex alternative splicing to yield multiple protein isoforms Oncogene 21 2768 2773 11965550 10.1038/sj.onc.1205363 1:CAS:528:DC%2BD38XjsVSms74%3D (Pubitemid 34478335)
4. O Wiedow JM Schröder H Gregory JA Young E Christophers 1990 Elafin: an elastase-specific inhibitor of human skin. Purification, characterization, and complete amino acid sequence J Biol Chem 265 14791 14795 2394696 1:CAS:528:DyaK3MXisF2l
5. RC Thompson K Ohlsson 1986 Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase Proc Natl Acad Sci U S A 83 6692 6696 3462719 10.1073/pnas.83.18.6692 1:CAS:528:DyaL28XmtVGgsrk%3D (Pubitemid 16002300)
6. M Schummer WV Ng RE Bumgarner PS Nelson B Schummer DW Bednarski L Hassell RL Baldwin BY Karlan L Hood 1999 Comparative hybridization of an array of 21,500 ovarian cDNAs for the discovery of genes overexpressed in ovarian carcinomas Gene 238 375 385 10570965 10.1016/S0378-1119(99)00342-X 1:CAS:528:DyaK1MXnt1ylt74%3D (Pubitemid 29446174)
7. I Hellström J Raycraft M Hayden-Ledbetter JA Ledbetter M Schummer M McIntosh C Drescher N Urban KE Hellström 2003 The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma Cancer Res 63 3695 3700 12839961 (Pubitemid 36793054)
8. E Anastasi T Granato GG Marchei V Viggiani B Colaprisca S Comploj MG Reale L Frati C Midulla 2010 Ovarian tumor marker HE4 is differently expressed during the phases of the menstrual cycle in healthy young women Tumour Biol. 31 411 415 20490961 10.1007/s13277-010-0049-1 1:CAS:528:DC%2BC3cXht1elt7bE
9. E Anastasi GG Marchei V Viggiani G Gennarini L Frati MG Reale 2010 HE4: a new potential early biomarker for the recurrence of ovarian cancer Tumour Biol. 31 113 119 20358424 10.1007/s13277-009-0015-y 1:CAS:528:DC%2BC3cXktFOis7k%3D
10. I Hellstrom PJ Heagerty EM Swisher P Liu J Jaffar K Agnew KE Hellstrom 2010 Detection of the HE4 protein in urine as a biomarker for ovarian neoplasms Cancer Lett 296 43 48 20381233 10.1016/j.canlet.2010.03.013 1:CAS:528: DC%2BC3cXovFymsbw%3D
11. L Bingle SS Cross AS High WA Wallace D Rassl G Yuan I Hellstrom MA Campos CD Bingle 2006 WFDC2 (HE4): a potential role in the innate immunity of the oral cavity and respiratory tract and the development of adenocarcinomas of the lung Respir Res 7 61 70 16600032 10.1186/1465-9921-7-61
12. MT Galgano GM Hampton HF Frierson Jr 2006 Comprehensive analysis of HE4 expression in normal and malignant human tissues Mod Pathol 19 847 853 16607372 1:CAS:528:DC%2BD28Xkslels70%3D (Pubitemid 43780455)
13. S Yamashita K Tokuishi T Hashimoto T Moroga M Kmei K Ono M Miyawaki S Takeno M Chujo S Yamamoto K Kawahara 2011 Prognostic significance of HE4 expression in pulmonary adenocarcinoma Tumor Biol. 32 265 271 10.1007/s13277-010-0118-5 1:CAS:528:DC%2BC3MXitleitr0%3D
14. M Wagner K Schmelz C Wuchter WD Ludwig B Dörken I Tamm 2006 In vivo expression of survivin and its splice variant survivin-2B: impact on clinical outcome in acute myeloid leukemia Int J Cancer 119 1291 1297 16619249 10.1002/ijc.21995 1:CAS:528:DC%2BD28XovVOru7Y%3D (Pubitemid 44258802)
15. R Drapkin HH von Horsten Y Lin SC Mok CP Crum WR Welch JL Hecht 2005 Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas Cancer Res 65 2162 2169 15781627 10.1158/0008-5472.CAN-04-3924 1:CAS:528:DC%2BD2MXisFGgurY%3D (Pubitemid 40490123)
16. N Scholler M Crawford A Sato CW Drescher KC O'Briant N Kiviat GL Anderson N Urban 2006 Bead-based ELISA for validation of ovarian cancer early detection markers Clin Cancer Res 12 2117 2124 16609024 10.1158/1078-0432.CCR-05-2007 1:CAS:528:DC%2BD28XjtlChsrg%3D
17. D Bouchard D Morisset Y Bourbonnais GM Tremblay 2006 Proteins with whey-acidic-protein motifs and cancer Lancet Oncol. 7 167 74 16455481 10.1016/S1470-2045(06)70579-4 1:CAS:528:DC%2BD28XhtFWiu7s%3D (Pubitemid 43159503)
18. E Bignotti M Ragnoli L Zanotti S Calza M Falchetti S Lonardi S Bergamelli E Bandiera RA Tassi C Romani P Todeschini FE Odicino F Facchetti S Pecorelli A Ravaggi 2011 Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients Br J Cancer 104 1418 25 21468050 10.1038/bjc.2011.109 1:CAS:528:DC%2BC3MXlt1GktLo%3D
19. NB Berry YM Cho MA Harrington SD Williams J Foley KP Nephew 2004 Transcriptional targeting in ovarian cancer cells using the human epididymis protein 4 promoter Gynecol Oncol 92 896 904 14984958 10.1016/j.ygyno.2003.12.024 1:CAS:528:DC%2BD2cXhsVOns7c%3D (Pubitemid 38251394)